Niek A. Vermuë

625 total citations
21 papers, 518 citations indexed

About

Niek A. Vermuë is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Niek A. Vermuë has authored 21 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 8 papers in Physiology and 5 papers in Molecular Biology. Recurrent topics in Niek A. Vermuë's work include Inhalation and Respiratory Drug Delivery (9 papers), Asthma and respiratory diseases (6 papers) and Neuroscience and Neuropharmacology Research (3 papers). Niek A. Vermuë is often cited by papers focused on Inhalation and Respiratory Drug Delivery (9 papers), Asthma and respiratory diseases (6 papers) and Neuroscience and Neuropharmacology Research (3 papers). Niek A. Vermuë collaborates with scholars based in Netherlands and Poland. Niek A. Vermuë's co-authors include Floris P. J. T. Rutjes, Michał Rachwalski, Johan Molema, H. Folgering, M.E.A.C. Broeders, Wim C.J. Hop, Adriaan den Hertog, Paul Mulder, Klaas Nicolay and Marjoke F. Debets and has published in prestigious journals such as Chemical Society Reviews, FEBS Letters and European Respiratory Journal.

In The Last Decade

Niek A. Vermuë

20 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Niek A. Vermuë Netherlands 11 270 234 125 98 40 21 518
David H. Richards United Kingdom 14 102 0.4× 159 0.7× 80 0.6× 102 1.0× 11 0.3× 23 608
Hannah M. König Germany 8 60 0.2× 123 0.5× 199 1.6× 249 2.5× 92 2.3× 9 899
Jie Lv China 13 49 0.2× 75 0.3× 21 0.2× 140 1.4× 120 3.0× 28 465
J. Castells Spain 15 51 0.2× 48 0.2× 278 2.2× 124 1.3× 24 0.6× 37 518
Kavita Sharma India 8 29 0.1× 127 0.5× 59 0.5× 91 0.9× 91 2.3× 17 398
Guoqiang Li China 11 37 0.1× 37 0.2× 32 0.3× 137 1.4× 77 1.9× 39 476
Sam J. Harbo United States 10 86 0.3× 63 0.3× 67 0.5× 74 0.8× 90 2.3× 14 403
Martin Jäger Germany 12 113 0.4× 69 0.3× 53 0.4× 121 1.2× 12 0.3× 24 473
Jia Gao China 10 92 0.3× 25 0.1× 68 0.5× 168 1.7× 43 1.1× 24 395
A. D. Vasilyeva Russia 12 103 0.4× 51 0.2× 25 0.2× 86 0.9× 36 0.9× 41 315

Countries citing papers authored by Niek A. Vermuë

Since Specialization
Citations

This map shows the geographic impact of Niek A. Vermuë's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niek A. Vermuë with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niek A. Vermuë more than expected).

Fields of papers citing papers by Niek A. Vermuë

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Niek A. Vermuë. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niek A. Vermuë. The network helps show where Niek A. Vermuë may publish in the future.

Co-authorship network of co-authors of Niek A. Vermuë

This figure shows the co-authorship network connecting the top 25 collaborators of Niek A. Vermuë. A scholar is included among the top collaborators of Niek A. Vermuë based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Niek A. Vermuë. Niek A. Vermuë is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eldijk, Mark B. van, et al.. (2014). Synthesis and Self-Assembly of Well-Defined Elastin-Like Polypeptide–Poly(ethylene glycol) Conjugates. Biomacromolecules. 15(7). 2751–2759. 44 indexed citations
2.
Rachwalski, Michał, Niek A. Vermuë, & Floris P. J. T. Rutjes. (2013). Recent advances in enzymatic and chemical deracemisation of racemic compounds. Chemical Society Reviews. 42(24). 9268–9268. 148 indexed citations
3.
Palen, Job van der, et al.. (2007). Comparison of The Diskus ® Inhaler And The Handihaler ® Regarding Preference And Ease of Use. Journal of Aerosol Medicine. 20(1). 38–44. 31 indexed citations
4.
Hop, WCJ, et al.. (2005). Efficacy of fluticasone on cough: a randomised controlled trial. European Respiratory Journal. 25(1). 147–152. 37 indexed citations
5.
Dekhuijzen, P.N.R., et al.. (2005). From the authors. European Respiratory Journal. 26(1). 181.2–182.
6.
Broeders, M.E.A.C., Johan Molema, Wim C.J. Hop, Niek A. Vermuë, & H. Folgering. (2004). The course of inhalation profiles during an exacerbation of obstructive lung disease. Respiratory Medicine. 98(12). 1173–1179. 65 indexed citations
7.
Molema, Johan, et al.. (2003). Does the inhalation device affect the bronchodilatory dose response curve of salbutamol in asthma and chronic obstructive pulmonary disease patients?. European Journal of Clinical Pharmacology. 59(5-6). 449–455. 11 indexed citations
8.
Kamps, Arvid W.A., et al.. (2002). Children with mild asthma: do they benefit from inhaled corticosteroids?. European Respiratory Journal. 20(6). 1470–1475. 22 indexed citations
9.
Hop, Wim C.J., et al.. (2002). Characteristics of adults with persistent cough in general practice. Primary Care Respiratory Journal. 11(2). 69–69. 3 indexed citations
10.
Broeders, M.E.A.C., Johan Molema, Niek A. Vermuë, & H. Folgering. (2001). Peak inspiratory flow rate and slope of the inhalation profiles in dry powder inhalers. European Respiratory Journal. 18(5). 780–783. 55 indexed citations
11.
12.
Hendriks, Han, et al.. (1998). Handling of a spacer (Babyhaler) for inhalation therapy in 0- to 3-year-old children.. Journal of Aerosol Science. 35. 297–304. 2 indexed citations
13.
Hendriks, Han, et al.. (1998). Handling of a Spacer (Babyhaler®) for Inhalation Therapy in 0- to 3-Year-Old Children. Journal of Asthma. 35(3). 297–304. 10 indexed citations
14.
Vermuë, Niek A., et al.. (1988). The prostaglandin response in guinea-pig taenia caeci and trachea smooth muscle of different ages. European Journal of Pharmacology. 147(2). 273–277. 6 indexed citations
15.
Vermuë, Niek A., et al.. (1988). Pharmacological profile of a chromanamine analogue (DP-6OH-3CA) of the selective presynaptic dopamine agonist N, N-dipropyl-7-hydroxy-2-aminotetralin. Journal of Pharmacy and Pharmacology. 40(8). 574–577. 1 indexed citations
16.
Vermuë, Niek A., Bernard Kaptein, Pieter G. Tepper, Jan B. De Vries, & A. S. Horn. (1988). Pharmacological profile of N,N dipropyl-8-hydroxy-3-chromanamine, an oxygen isostere of the dopamine agonist N,N dipropyl-5-hydroxy-2-aminotetralin with enhanced presynaptic selectivity.. PubMed. 293. 37–56. 1 indexed citations
17.
Kaptein, Bernard, et al.. (1988). Synthesis and dopaminergic activity of a new oxygen isostere of the 2-aminotetralins: N,N-dipropyl-8-hydroxy-3-chromanamine. European Journal of Medicinal Chemistry. 23(4). 325–328. 9 indexed citations
18.
Vermuë, Niek A. & Adriaan den Hertog. (1987). The action of prostaglandins on ureter smooth muscle of guinea-pig. European Journal of Pharmacology. 142(1). 163–167. 15 indexed citations
19.
Vermuë, Niek A., Adriaan den Hertog, & J. Zaagsma. (1987). Desensitization of PGE2 and PGI2 induced contractions in different smooth muscles of guinea-pig unmasking relaxing properties of prostanoids. European Journal of Pharmacology. 144(3). 399–403. 7 indexed citations
20.
Vermuë, Niek A. & Klaas Nicolay. (1983). Energetics of smooth muscle taenia caecum of guinea‐pig: a 31P‐NMR study. FEBS Letters. 156(2). 293–297. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026